Competition between two of the biggest names in weight-loss drugs has moved from pharmacies and television screens into the ...

Millions of older adults on Medicare prescription drug coverage could face higher monthly costs in 2027. The Trump ...

A conservative group has launched a campaign opposing an advertisement that raises awareness of the HIV prevention drug PrEP, ...

Stock was down 9.5% after the company’s experimental medicine ziltivekimab didn’t achieve the expected risk reduction for ...

Novo Nordisk said on Friday it is seeking a preliminary U.S. court injunction to immediately block obesity and diabetes drug ...

By Jonathan Stempel NEW YORK, July 30 (Reuters) - A federal appeals court on Thursday revived portions of nationwide litigation in which consumers accused drugmakers such as Procter & Gamble and ...

GLP-1 drugs such as semaglutide and tirzepatide are transforming obesity and diabetes care in India, but experts warn that ...

Willow Health Services agreed with the BBB National Programs' National Advertising Division to discontinue certain ...

An FDA panel with ties to the industry recommended loosening regulations on six peptides over objections from FDA scientists ...

Novo Nordisk is escalating its legal battle against Eli Lilly over its GLP-1 drug marketing, notifying a federal court that ...

A key U.S. government report on mental health, substance use and addiction shows continued improvements in several metrics, ...

Worldwide, more than 55 million people suffer from dementia caused by Alzheimer's Disease (AD) and other conditions that destroy cells in the brain and nervous system. While there is no treatment to ...